Starch supplement increases survival rate for bone marrow transplant patients U of M: Starch supplement reduces risk of bone marrow transplant rejection

No time to read?
Get a summary

Scientists from Baylor College of Medicine and the University of Michigan (U of M) found that potato starch supplements may reduce the risk of graft-versus-host disease in people receiving bone marrow transplants. The research was published in the journal Nature Medicine.

Graft-versus-host disease is a major complication of bone marrow transplantation that occurs in almost half of patients and can be fatal. Previous studies have shown that changes in the normal gut microbiome and gut bacterial products (e.g., butyrate) contribute to worsening graft-versus-host disease.

In a new study, 10 bone marrow transplant patients at the University of Michigan took a nutritional supplement made from potato starch for more than 100 days. They had significantly increased levels of butyrate in their stool, which may indicate improved gut bacterial health.

Only one in 10 patients developed graft-versus-host disease, whereas typically about half of bone marrow transplant patients develop the disease. Taking the dietary supplement did not cause any negative side effects. Scientists believe that the supplement they developed could be an additional treatment for bone marrow transplant patients after further testing for effectiveness and safety.

Previously in the oral cavity to create A bacteria that causes periodontitis and reduces the chances of survival after a heart attack.

No time to read?
Get a summary
Previous Article

Agustinos fights but falls to Los Sauces (28-24)

Next Article

Bastrykin was instructed to report to him about immigrant teenagers who robbed a child